Skip Navigation


Glycobiology Advance Access first published online on February 6, 2008
This version published online on February 14, 2008
Glycobiology, doi:10.1093/glycob/cwn010
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrow All Versions of this Article:
18/5/353    most recent
cwn010v2
cwn010v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Prien, J. M.
Right arrow Articles by Reinhold, V. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Prien, J. M.
Right arrow Articles by Reinhold, V. N.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oxfordjournals.org

Differentiating N-linked Glycan Structural Isomers in Metastatic and Non- Metastatic Tumor Cells using Sequential Mass Spectrometry

Justin M. Prien{dagger}, Leanne C. Huysentruyt*, David J. Ashline{dagger}, Anthony J. Lapadula{dagger},{ddagger},, Thomas N. Seyfried* and Vernon N. Reinhold{dagger}

{dagger} The Glycomics Center, Division of Molecular, Cellular, and Biomedical Sciences
{ddagger} Department of Computer Science, University of New Hampshire, Durham, NH 03824
* Department of Biology, Boston College, Chestnut Hill, Massachusetts 02467

Received on January 13, 2008; accepted on February 1, 2008

In an effort to understand the role of molecular glycosylation in cancer a murine model has been used to characterize and fingerprint malignancies in established cell lines that manifest all the hallmarks of metastatic disease; spontaneous development, local invasion, intravasation, immune system survival, extravasation, and secondary tumor formation involving liver, kidney, spleen, lung, and brain. Using astrocyte cell controls, we compared N–linked glycosylation from a non-metastatic brain tumor cell line and two different metastatic brain tumor cells. Selected ions in each profile were disassembled by ion trap mass spectrometry (MSn) which exhibited multiple structural differences between each tissue. These unique structures were identified within isomeric compositions as pendant non–reducing termini of di-, and trisaccharide fragments, probably transparent to a tandem MS approach but distinctively not to sequential ion trap MSn detection.

Key words: carbohydrate / oligosaccharide / malignancy / biomarker / isomer


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
K. Aoki, M. Porterfield, S. S. Lee, B. Dong, K. Nguyen, K. H. McGlamry, and M. Tiemeyer
The Diversity of O-Linked Glycans Expressed during Drosophila melanogaster Development Reflects Stage- and Tissue-specific Requirements for Cell Signaling
J. Biol. Chem., October 31, 2008; 283(44): 30385 - 30400.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.